AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Use Of Nonprescription Products Common Among Young Women.

Women's Health Weekly

| September 13, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 SEP 13 - (NewsRx.com & NewsRx.net) -- Seven percent of survey respondents, including nearly 30% of young obese women, report using nonprescription weight loss products, according to an article in the August 22/29, 2001, issue of the Journal of the American Medical Association.

The authors warn that patients should inform their physicians about the use of these products because of the possible side effects.

Heidi Michels Blanck, PhD, at the National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, and colleagues surveyed 14,679 adults 18 years or older by telephone in five states (Florida, Iowa, Michigan, West Virginia, and Wisconsin) in 1998 about their use of nonprescription weight-loss products from 1996 through 1998. Respondents were asked questions about their use of prescription and nonprescription weight loss supplements, their height and weight, age, and diabetic status.

The authors found that 44% of the participants were normal weight, 36% were overweight, and 20% were obese (based on calculations of body mass index for each individual.) One-third reported that they were trying to lose weight and one-third reported that they were trying to maintain weight (JAMA, 2001;286:930-935).

Seven percent of the respondents reported using at least one nonprescription weight loss product during the previous two years. Women and younger adults were the most frequent users, as were respondents with higher body mass indexes. One percent reported use of ephedra products and 2% reported using phenylpropanolamine (PPA). Ephedra use has been linked to possible adverse health effects among persons with diabetes, hypertension, heart disease, and other conditions. PPA has been linked to reports of adverse cerebrovascular and cardiac events.

Michels Blanck and coworkers also found that ...

Related articles from newspapers, magazines, journals, and more
November 2008 Mayo Clinic Women's HealthSource Highlights 10 Symptoms Not To...
Newspaper article from: Blood Weekly November 20, 2008 700+ words
...System Disease, Knee Replacement, Medical Device, Paralysis, Surgery, Surgical Technology, Transient Ischemic Attack, Weight Loss, Women's Health, Mayo Clinic. This article was prepared by Blood Weekly editors from staff and other reports. Copyright...
Chromium Supplementation for Weight Loss.
Newspaper article from: Alternative Therapies in Women's Health May 1, 2003 700+ words
...Chromium Supplementation for Weight Loss By Donal P. OMathuna, PhD...popular over-the-counter weight-loss medications and associated...pharmaceuticals, many are turning to nonprescription weight-loss products, including dietary...
Data on weight loss detailed by A. Nazeri and co-authors.(Report)
Newspaper article from: Obesity & Diabetes Week June 22, 2009 700+ words
"We examined nonprescription weight-toss supplements marketed...are associated with weight-Loss supplements marketed...States report (see also Weight Loss). "We entered the key words ''weight-loss supplements'' and...
FDA panel approves GlaxoSmithKline weight-loss drug.
Newspaper article from: Pittsburgh Post-Gazette (Pittsburgh, PA) January 23, 2006 700+ words
...effort to bring the first nonprescription weight-loss drug to the market. Committee...provides gradual but meaningful weight loss." Dr. Alastair Wood, chairman...who shouldn't be on the weight-loss drug don't take it. But...
Glaxo and others ask FDA to treat weight loss claims as disease claims.(TOP OF...
Magazine article from: Nutraceuticals World June 1, 2008 700+ words
...the-counter (OTC) weight loss drug alli, filed the...supplements marketed for weight loss actually work, even...about 37.5% of the nonprescription weight control product market...statement: "We believe weight loss claims are legitimate...
CytoDyn Annual Meeting Set and GSK's Over-The-Counter Weight-Loss Drug Gets Key...
Press release article from: M2 Presswire January 26, 2006 700+ words
...GSK's Over-The-Counter Weight-Loss Drug Gets Key OK(C)1994...application to sell orlistat, a weight-loss drug, without a prescription...Alli would become the only nonprescription weight-loss drug with FDA approval. The...
Weight-loss pill's effects on liver investigated
Newspaper article from: The Boston Globe ASSOCIATED PRESS August 25, 2009 700+ words
...liver damage in patients taking alli, the only nonprescription weight-loss drug approved by the agency. Regulators said...established a direct relationship between the weight-loss treatments and liver injury, and advised patients...
Use Of Nonprescription Products Common Among Young Women.(survey of weight...
Newspaper article from: Medical Letter on the CDC & FDA September 16, 2001 700+ words
...women, report using nonprescription weight loss products, according...1998 about their use of nonprescription weight-loss products from 1996 through...use of prescription and nonprescription weight loss supplements, their height...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA